Prospective Study of Drug-induced Interstitial Lung Disease in Advanced Breast Cancer Patients Receiving Everolimus Plus Exemestane

BACKGROUND: Everolimus-related interstitial lung disease (ILD) (also: pneumonitis) poses a difficulty for physicians, as it is hard to discriminate ILD from other causes of respiratory symptoms and to decide on safe treatment continuation. OBJECTIVE: We investigated the capability of pulmonary funct...

Descripción completa

Detalles Bibliográficos
Autores principales: Willemsen, Annelieke E. C. A. B., Tol, Jolien, van Erp, Nielka P., Jonker, Marianne A., de Boer, Maaike, Meek, Bob, de Jong, Paul C., van Moorsel, Coline, Gerritsen, Winald R., Grutters, Jan C., van Herpen, Carla M. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6684805/
https://www.ncbi.nlm.nih.gov/pubmed/31325105
http://dx.doi.org/10.1007/s11523-019-00656-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6684805/
https://www.ncbi.nlm.nih.gov/pubmed/31325105
http://dx.doi.org/10.1007/s11523-019-00656-2

Ejemplares similares